Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Strongsville, Ohio


Purpose:

A 12-week evaluation of the safety and efficacy of dapsone gel 5% when used with tretinoin gel 0.025% compared with tretinoin gel 0.025% monotherapy in treating moderate to severe facial acne vulgaris


Criteria:

Inclusion Criteria: - Facial acne vulgaris characterized by the following: - 30-100 facial inflammatory lesions; and, 25-100 facial non-inflammatory lesions; - Stable disease, non-rapidly regressing facial acne vulgaris; and, less than or equal to 3 nodules and/or cysts (diameter greater than or equal to 1cm) - Female subjects of childbearing potential must have a negative pregnancy test at baseline and practice reliable method of contraception throughout the study Exclusion Criteria: - Non-compliance with washout period; - History of clinically significant anemia or hemolysis; - Skin disease/disorder that might interfere with diagnosis or evaluation of acne vulgaris; - Allergy or sensitivity to any component of the test medications


NCT ID:

NCT00835198


Primary Contact:

Study Director
Medical Director
Allergan


Backup Contact:

N/A


Location Contact:

Strongsville, Ohio
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.